000			03012nam a22003855i 4500
710	2		_aSpringerLink (Online service) _0Local _9106996
988			_aSpringer_Medicine_2016
999			_c86640 _d86640 _x1
001			86640
003			ES-MaUEC
005			20230207040608.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			160120s2016 ii | s |||| 0|eng d
020			_a9788132226079
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRS431 .R34 _b2016 EB
100			_aKnapp, F. F. (Russ) _9100507
245	1	0	_aRadiopharmaceuticals for Therapy _cby F F (Russ) Knapp, Ashutosh Dash
250			_aprimera edición
264		1	_aNew Delhi _bSpringer India _c2016
300			_a1 recurso en línea (XXIV, 347 páginas) _b157 ilustraciones, 72 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
520			_aThis book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT). Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.
650		7	_9141446 _aProductos radiofarmacéuticos _2embne
700	1		_aDash, Ashutosh _0Local _eautor _9100508
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-81-322-2607-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9788132226079
907			_a.b12959182 _b10-10-17 _c21-11-16
942			_2lcc _cLE
945			_aEBOOK EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11615965 _z30-06-17
998			_b05/2020 _dz _eu _feng _gii _h0